Dublin, May 06, 2022 (GLOBE NEWSWIRE) -- The "Global Blood Collection Devices Market Size, Share & Industry Trends Analysis Report By End User, By Product, By Tubes Type, By Plasma/whole-blood Tubes Type, By Tubes System Type, By Method, By Application, By Regional Outlook and Forecast, 2021-2027" report has been added to ResearchAndMarkets.com's offering. The Global Blood Collection Devices Market size is expected to reach $8 billion by 2027, rising at a market growth of 6.2% CAGR during the forecast period. Blood processing and collection are two significant steps to be performed in preanalytical laboratory testing. Legitimate blood collection and on-time processing by skilled staff utilizing efficient devices are required in order to assure test reliability. Blood collection devices have been considered inert specimen carriers. That is why laboratories are investing a bit of effort to access innovative blood collection devices with the help of which they are not required to monitor the device performance continuously. Additionally, blood is collected with the help of blood donation processes such as WB (whole blood), and after that, various components can easily be separated from it by the process of apheresis. The quantity of blood drawn depends upon the person and ought not to be more than 1% of the donor's weight. The collection can be done manually or automatically by the use of automated equipment that can even collect particular components of blood. Various advanced devices are being introduced in the market such as hematology analyzers. There are computerized and highly specialized machines which count the number of blood platelets, red & white blood cells, hematocrit level & hemoglobin present in the blood sample. With the help of a needle, phlebotomist is expected to rupture a vein and collect the blood into a glass tube which contains ETDA as additives to prevent blood coagulation. In the past few years, some diseases such as coronavirus have put human health into a threat all over the world. Diagnostics is the foremost step to be taken for the treatment of infectious diseases. It is an important step to identify efficient diagnostic strategies urgently to provide better treatment. Furthermore, effective diagnostic techniques are also important for the identification & better treatment of diseases. COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic is an unexpected public health challenge for the whole world. The pandemic is anticipated to have a substantial impact on the blood circulation device market. Independent laboratories as well as hospitals were confused in deciding either to recommend to consult with laboratory hematologists for tests that involve higher risk or not offer tests that couldn't be performed securely. This has impacted the market adversely in the initial months of the pandemic resulting in a decline in the use of blood collection devices. Whereas, rising alert and the increasing testing volumes, coupled with the requirement for regular body & health checkups will result in the growth of blood collection devices. Results presently take around four to six days for the normal population, significantly longer than two to three days required before. This is due to the prioritization of tests for symptomatic healthcare workers & hospital patients that on average take one day which is resulting in the delayed cycle. Market Growth Factors:
Technological advancements in blood collection procedures and products
Collection of blood samples of patients from difficult venous access (DVA) is not easy and even is impossible sometimes. The traditional products used for blood collection products are sometimes unable to collect blood samples efficiently. This may lead to repeated attempts for collecting blood. Also, this increases the risk of anemia & the transfer of blood-borne pathogens to phlebotomists. In order to get over this issue, innovative hematology tube designs have been launched that support capillary blood collection along with reducing the risk of processing & collection errors in patients with DVA. Rising prevalence of inherited blood disorders
If there is an issue with the blood, it may affect the total health of the body. Some types of blood disorders are platelet disorders, bleeding problems & excessive clotting that may affect the blood clots; anemia that happens when blood do not let the oxygen go through the rest of your body, blood cancers like myeloma & leukemia and eosinophilic disorders that is an issue with the particular type of white blood cells. As per the information provided by World Health Organization, hemoglobin disorders were mainly found in 60% of 229 countries and were affecting 75% of births. This encourages policymakers to find the most efficient treatment strategies. Hemophilia A affects 1 in every 5000 male births in the United States. Every year approximately 400 babies are born with hemophilia. Market Restraining Factors
High cost of automated blood collection devices
The cost involved in initial investment for the adoption of automated blood collection by the use of apheresis devices involves high costs as compared to blood collection. Also, the cost of therapeutic apheresis is high as it further involves the cost of disposables. The higher cost of these devices is leading to the lower adoption of automated blood collection devices. As many of the smaller blood banks, hospitals cannot afford to use these blood collection devices. In addition, the cost of apheresis therapy is a matter of concern for the whole world. The cost for individual apheresis treatments may widely differ.
Key Topics Covered: Chapter 1. Market Scope & Methodology Chapter 2. Market Overview 2.1 Introduction 2.1.1 Overview 2.1.1.1 Market Composition and Scenario 2.2 Key Factors Impacting the Market 2.2.1 Market Drivers 2.2.2 Market Restraints Chapter 3. Competition Analysis - Global 3.1 KBV Cardinal Matrix 3.2 Recent Industry Wide Strategic Developments 3.2.1 Partnerships, Collaborations and Agreements 3.2.2 Product Launches and Product Expansions 3.2.3 Acquisition and Mergers 3.2.4 Geographical Expansions 3.3 Top Winning Strategies 3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021) Chapter 4. Global Blood Collection Devices Market by End User 4.1 Global Hospitals, Ambulatory Surgical Centers, & Nursing Homes Market by Region 4.2 Global Diagnostic & Pathology Laboratories Market by Region 4.3 Global Blood Banks Market by Region 4.4 Global Others Market by Region Chapter 5. Global Blood Collection Devices Market by Product 5.1 Global Blood Collection Tubes Market by Region 5.2 Global Blood Collection Tubes Market by Type 5.2.1 Global Plasma/whole-blood Tubes Market by Region 5.2.2 Global Plasma/whole-blood Tubes Market by Type 5.2.2.1 Global EDTA Tubes Market by Region 5.2.2.2 Global Heparin Tubes Market by Region 5.2.2.3 Global Coagulation Tubes Market by Region 5.2.2.4 Global Glucose Tubes Market by Region 5.2.2.5 Global Others Market by Region 5.2.3 Global Serum Tubes Market by Region 5.3 Global Blood Collection Tubes Market by System Type 5.3.1 Global Vacuum Tubes Market by Region 5.3.2 Global Non-Vacuum Tubes Market by Region 5.4 Global Needles & Syringes Market by Region 5.5 Global Blood Bags Market by Region 5.6 Global Blood Collection Systems/Monitors Market by Region 5.7 Global Lancets Market by Region Chapter 6. Global Blood Collection Devices Market by Method 6.1 Global Manual Blood Collection Market by Region 6.2 Global Automatic Blood Collection Market by Region Chapter 7. Global Blood Collection Devices Market by Application 7.1 Global Diagnostics Market by Region 7.2 Global Therapeutics Market by Region Chapter 8. Global Blood Collection Devices Market by Region Chapter 9. Company Profiles 9.1 Sarstedt AG & Company 9.1.1 Company Overview 9.1.2 Recent strategies and developments: 9.1.2.1 Acquisition and Mergers 9.2 ICU Medical, Inc. 9.2.1 Company Overview 9.2.2 Financial Analysis 9.2.3 Regional Analysis 9.2.4 Research & Development Expenses 9.3 Grifols, S.A 9.3.1 Company Overview 9.3.2 Financial Analysis 9.3.3 Regional & Segmental Analysis 9.3.4 Research & Development Expenses 9.4 Retractable Technologies, Inc. 9.4.1 Company Overview 9.4.2 Financial Analysis 9.4.3 Segmental Analysis 9.4.4 Research & Development Expenses 9.5 Quest Diagnostics Incorporated 9.5.1 Company Overview 9.5.2 Financial Analysis 9.5.3 Segmental Analysis 9.5.4 Recent strategies and developments: 9.5.4.1 Partnerships, Collaborations, and Agreements: 9.5.4.2 Product Launches and Product Expansions: 9.6 Becton, Dickinson and Company 9.6.1 Company Overview 9.6.2 Financial Analysis 9.6.3 Segmental and Regional Analysis 9.6.4 Research & Development Expense 9.6.5 Recent strategies and developments: 9.6.5.1 Partnerships, Collaborations, and Agreements: 9.7 Haemonetics Corporation 9.7.1 Company Overview 9.7.2 Financial Analysis 9.7.3 Regional & Segmental Analysis 9.7.4 Research & Development Expenses 9.8 Terumo Corporation 9.8.1 Company Overview 9.8.2 Financial Analysis 9.8.3 Segmental Analysis 9.8.4 Recent strategies and developments: 9.8.4.1 Partnerships, Collaborations, and Agreements: 9.8.4.2 Product Launches and Product Expansions: 9.8.4.3 Geographical Expansions: 9.9 Fresenius SE & Co. KGaA 9.9.1 Company Overview 9.9.2 Financial Analysis 9.9.3 Segmental and Regional Analysis 9.9.4 Research & Development Expenses 9.10. Cardinal Health, Inc. 9.10.1 Company Overview 9.10.2 Financial Analysis 9.10.3 Segmental and Regional Analysis
For more information about this report visit https://www.researchandmarkets.com/r/2na746
What happened Shares of drugmaker Novavax (NASDAQ: NVAX) are up to the tune of 18.9% as of 2:11 p.m. ET Friday, according to data from S&P Global Market Intelligence, thanks to a confluence of events that work in the company's favor.
Mirati is unlikely to carve out a share of the lung cancer market, analysts said Friday as MRTX stock collapsed on a testing disappointment.
For the third year, Americans are greeting the unofficial start of summer shadowed by the specter of the coronavirus amid rising covid-19 cases and hospitalizations across the country. The United States is recording more than 100,000 infections a day - at least five times higher than this point last year - as it confronts the most transmissible versions of the virus yet. Immunity built up as a result of the record winter outbreak appears to provide little protection against the latest variants,
Florida counties from St. Lucie to Monroe, including Palm Beach County, are at a "medium" health care risk level.
Hundreds of cancer patients appealed to a judge to show leniency towards a cannabis dealer because he gave drugs only to people in ill health.
Shoppers returned to the malls of Beijing on Sunday as the Chinese capital relaxed pandemic restrictions after declaring a small but persistent COVID-19 outbreak effectively under control. A partial reopening of stores and offices in Beijing was welcomed by a weary populace and struggling shopkeepers eager for life to return to normal. Coupled with a gradual easing of restrictions in Shanghai, it signaled that the worst is over in the twin outbreaks in China's most prominent cities.
Billie Eilish is not one to shy away from sharing her personal struggles with the public. The "Happier Than Ever" singer has spoken up about issues surrounding her mental health and body image, and she's now opening up about Tourette syndrome - a diagnosis characterized by sudden, repetitive, rapid, and unwanted movements or vocal sounds called tics, per the National Institute of Neurological Disorders and Stroke.
There is no magic pill that will cure obesity, a condition that affects over 40% of adults in the United States. But there is a new type of medicine that is a potential game-changer. It's an anti-obesity medication, and doctors say that part of what makes it unique is how it's prescribed: It is used to treat obesity as the chronic metabolic disease that it is rather than perpetuating the misconception that obesity is a problem that can be overcome by willpower. Read on to find out more—and to en
Medicare recipients will get a premium reduction — but not until next year — reflecting what Health and Human Services Secretary Xavier Becerra said Friday was an overestimate in costs of covering an expensive and controversial new Alzheimer's drug. Becerra’s statement said the 2022 premium should be adjusted downward but legal and operational hurdles prevented officials from doing that in the middle of the year. Medicare Part B premiums jumped by $22 a month, to $170.10, for 2022, in part because of the cost of the drug Aduhelm, which was approved despite weak evidence that it could slow the progression of Alzheimer's.
Before you take any new medication, whether prescription or over-the-counter (OTC), it's essential to weigh the potential risks and benefits. If the side effects could cause more harm than they're worth, that's a good reason to talk to your doctor about possible alternatives. In particular, experts are warning that some types of medication may raise your blood pressure, or cause your blood pressure medication to fail—a potentially serious side effect, especially for people already at heightened
A Brooklyn judge sprang a violent mobster from prison because he said the federal Bureau of Prisons did a lousy job taking care of the wiseguy’s medical problems. Federal Court Judge Raymond Dearie issued a scathing ruling Thursday, saying the feds weren’t competently treating made man Vincent “Chickie” DeMartino’s maladies. The goodfella had more than two years left of his 25-year sentence ...
"The key to treating dementia is prevention," says Dr. Sanjay Gupta, CNN's chief medical correspondent and a practicing neurosurgeon, in his book Stay Sharp: Build a Better Brain at Any Age. Gupta notes that brain changes that result in dementia have been found to begin 20 to 30 years before a diagnosis, making prevention an urgent and worthy goal. "And it just so happens that the same things you can do to reduce your risk for the disease are what you can do to improve your quality of life as yo
While many of us optimistically hoped that the coronavirus would be a distant memory at this point, that is hardly the reality. We entered 2022 in one of the worst surges throughout the entire pandemic, with the Omicron variant creating record high infection numbers across the U.S. And despite COVID numbers falling substantially throughout February and March, they are back on the rise again. In the last week, the U.S. has reported an average of almost 110,000 new infections every day, according
Your guide to understanding where monkeypox came from, how it spreads, who can get vaccinated and how big a threat it is.
With Memorial Day near, many Americans are looking to fire up the grill. Just make sure you do it safely. Here are tips for cooking safely.
Your risk of developing dementia is determined by a wide range of factors—some of which you can control, and others you can't. Your family history, for instance, is simply the luck of the draw, and much as you might wish to, you can't change your age. On the other hand, things like your diet, alcohol intake, and medication use are considered modifiable.A new report warns that taking one medication in particular may put you at increased risk of later developing dementia—and that's hardly this dru
It's crucial to factor in rest days too
US Senate is expected to vote on the Honoring our PACT Act in early June with veterans advocate Jon Stewart saying only six more senators are needed to pass the landmark bill
When organizers earlier this year settled on a summer opening for a new women's health clinic in Wyoming, they felt upbeat about their plans even as they knew they would face opposition to what will be the only such clinic to offer abortions in the state. Things got more tense after a leaked draft of a U.S. Supreme Court ruling that, if finalized, would likely make abortions illegal in Wyoming and half of the states. None of it has derailed plans to open the clinic — a rarity in heavily Republican parts of the United States where most abortion providers at the moment are fighting just to stay in business, let alone expand services.
You probably know that the foods you eat can have an impact on your brain over time. In fact, some foods can actually impair your memory and increase your risk of neurodegenerative disorders, while others can help stave off cognitive decline.Now, a new study finds that eating cranberries could help keep you sharp as you age.In the study, published in the journal Frontiers in Nutrition, researchers examined a group of 60 adults ages 50-80 for a period of 12 weeks, supplementing some of their diet